BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sasaki R, Kanda T, Kato N, Yokosuka O, Moriyama M. Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response. World J Hepatol 2018; 10(12): 898-906 [PMID: 30631394 DOI: 10.4254/wjh.v10.i12.898]
URL: https://www.wjgnet.com/1007-9327/full/v10/i12/898.htm
Number Citing Articles
1
Letícia Bomfim Campos, Nathália Alves Araújo de Almeida, Catarina Góis de Santana, Evorah Nascimento Pereira Barbosa, Marco Aurelio Pereira Horta, Márcia Amendola Pires, Carlos Eduardo Brandão Mello, Vanessa Salete de Paula, José Júnior França de Barros. Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBVViruses 2023; 15(1): 187 doi: 10.3390/v15010187
2
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A ReviewInternational Journal of Molecular Sciences 2019; 20(6): 1358 doi: 10.3390/ijms20061358
3
Isabela Gomes Ribeiro, Jordana Grazziela Alves Coelho-dos-Reis, Jordana Rodrigues Barbosa Fradico, Ismael Artur da Costa-Rocha, Luciana Diniz Silva, Lucy Ana dos Santos Fonseca, Rhaissa Carvalho Said Stancioli, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Rosângela Teixeira. Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapyAntiviral Research 2021; 190: 105073 doi: 10.1016/j.antiviral.2021.105073
4
Mousumi Khatun, Ranjit Ray, Ratna B. Ray. Mechanisms and Therapy of Liver CancerAdvances in Cancer Research 2021; 149: 103 doi: 10.1016/bs.acr.2020.10.003
5
O Adekanle, MM Oje, DA Ndububa. Malignant transformation of cirrhotic liverNigerian Journal of Health Sciences 2020; 20(2): 37 doi: 10.4103/njhs.njhs_30_20
6
Yuki Haga, Ranjit Ray, Ratna B. Ray. Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical ModelMolecular Carcinogenesis 2024;  doi: 10.1002/mc.23827